C-reactive protein and other inflammatory risk markers in acute coronary syndromes
Gavin J. Blake, MB, MSc, MRCPI* and
Paul M. Ridker, MD, MPH*,*
* Center for Cardiovascular Disease Prevention, the Leducq Center for Cardiovascular Research, and the Cardiovascular Division, Department of Medicine, Brigham and Womens Hospital, Harvard Medical School, Boston, Massachusetts, UK
Manuscript received May 7, 2002;
revised manuscript received October 11, 2002,
accepted November 27, 2002.
*
Reprint requests and correspondence: Dr. Paul M. Ridker, Center for Cardiovascular Disease Prevention, Brigham and Womens Hospital, 900 Commonwealth Avenue East, Boston, Massachusetts 02215, UK. pridker{at}partners.org
Markers of myocyte necrosis such as cardiac troponin or creatine kinase-myocardial band are invaluable tools for risk stratification among patients presenting with acute coronary syndromes (ACS). Nonetheless, many patients without any evidence of myocyte necrosis may be at high risk for recurrent ischemic events. In consideration of the important role that inflammatory processes play in determining plaque stability, recent work has focused on whether plasma markers of inflammation may help improve risk stratification. Of these markers, C-reactive protein (CRP) has been the most widely studied, and there is now robust evidence that CRP is a strong predictor of cardiovascular risk among apparently healthy individuals, patients undergoing elective revascularization procedures, and patients presenting with ACS. Moreover, even among patients with troponin-negative ACS, elevated levels of CRP are predictive of future risk. Other, more upstream markers of the inflammatory cascade, such as interleukin (IL)-6, have also been found to be predictive of recurrent vascular instability. A recent report from the second FRagmin during InStability in Coronary artery disease trial investigators suggests that elevated levels of an inflammatory marker such as IL-6 may indicate which patients may benefit most from an early invasive strategy. Other inflammatory markers currently under investigation include lipoprotein-associated phospholipase A2, myeloperoxidase, and pregnancy-associated plasma protein A. Of all these novel markers, CRP appears to meet most of the criteria required for potential clinical application. Furthermore, the benefits of lifestyle modification and drug therapy with aspirin or statins may be most marked among those with elevated CRP levels.
|
Abbreviations and Acronyms
| | ACS | = acute coronary syndrome(s) | | BNP | = B-type natriuretic peptide | | CAD | = coronary artery disease | | CK-MB | = creatine kinase-myocardial band | | CRP | = C-reactive protein | | IL | = interleukin | | LDL | = low-density lipoprotein | | Lp-PLA2 | = lipoprotein-associated phospholipase A2 | | MI | = myocardial infarction | | MPO | = myeloperoxidase | | PAPP-A | = pregnancy-associated plasma protein A |
|
This article has been cited by other articles:

|
 |

|
 |
 
B. Molins, E. Pena, G. Vilahur, C. Mendieta, M. Slevin, and L. Badimon
C-Reactive Protein Isoforms Differ in Their Effects on Thrombus Growth
Arterioscler Thromb Vasc Biol,
December 1, 2008;
28(12):
2239 - 2246.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Zeller, C. Korandji, J.-C. Guilland, P. Sicard, C. Vergely, L. Lorgis, J.-C. Beer, L. Duvillard, A.-C. Lagrost, D. Moreau, et al.
Impact of Asymmetric Dimethylarginine on Mortality After Acute Myocardial Infarction
Arterioscler Thromb Vasc Biol,
May 1, 2008;
28(5):
954 - 960.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Malarstig, S. Sigurdsson, P. Eriksson, G. Paulsson-Berne, U. Hedin, L. Wallentin, A. Siegbahn, A. Hamsten, and A.-C. Syvanen
Variants of the Interferon Regulatory Factor 5 Gene Regulate Expression of IRF5 mRNA in Atherosclerotic Tissue But Are Not Associated With Myocardial Infarction
Arterioscler Thromb Vasc Biol,
May 1, 2008;
28(5):
975 - 982.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Otter, M. Winter, W. Doering, E. Standl, and O. Schnell
C-Reactive Protein in Diabetic and Nondiabetic Patients With Acute Myocardial Infarction
Diabetes Care,
December 1, 2007;
30(12):
3080 - 3082.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. M. Scirica, D. A. Morrow, C. P. Cannon, J. A. de Lemos, S. Murphy, M. S. Sabatine, S. D. Wiviott, N. Rifai, C. H. McCabe, E. Braunwald, et al.
Clinical Application of C-Reactive Protein Across the Spectrum of Acute Coronary Syndromes
Clin. Chem.,
October 1, 2007;
53(10):
1800 - 1807.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. M. Lepper, C. Schumann, K. Triantafilou, F. M. Rasche, T. Schuster, H. Frank, E. M. Schneider, M. Triantafilou, and M. von Eynatten
Association of Lipopolysaccharide-Binding Protein and Coronary Artery Disease in Men
J. Am. Coll. Cardiol.,
July 3, 2007;
50(1):
25 - 31.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Ramzy, V. Rao, L. C. Tumiati, N. Xu, R. Sheshgiri, J. Jackman, D. H. Delgado, and H. J. Ross
Endothelin-1 accentuates the proatherosclerotic effects associated with C-reactive protein
J. Thorac. Cardiovasc. Surg.,
May 1, 2007;
133(5):
1137 - 1146.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
NACB WRITING GROUP MEMBERS, D. A. Morrow, C. P. Cannon, R. L. Jesse, L. K. Newby, J. Ravkilde, A. B. Storrow, A. H.B. Wu, and R. H. Christenson
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical Characteristics and Utilization of Biochemical Markers in Acute Coronary Syndromes
Circulation,
April 3, 2007;
115(13):
e356 - e375.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
NACB WRITING GROUP MEMBERS, D. A. Morrow, C. P. Cannon, R. L. Jesse, L. K. Newby, J. Ravkilde, A. B. Storrow, A. H.B. Wu, R. H. Christenson, NACB COMMITTEE MEMBERS, et al.
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical Characteristics and Utilization of Biochemical Markers in Acute Coronary Syndromes
Clin. Chem.,
April 1, 2007;
53(4):
552 - 574.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Dentali, E. Romualdi, and W. Ageno
The metabolic syndrome and the risk of thrombosis
Haematologica,
March 1, 2007;
92(3):
297 - 299.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. N. Tziakas, G. K. Chalikias, C. O. Antonoglou, S. Veletza, I. K. Tentes, A. X. Kortsaris, D. I. Hatseras, and J. C. Kaski
Apolipoprotein E Genotype and Circulating Interleukin-10 Levels in Patients With Stable and Unstable Coronary Artery Disease
J. Am. Coll. Cardiol.,
December 19, 2006;
48(12):
2471 - 2481.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Secchiero, R. Candido, F. Corallini, S. Zacchigna, B. Toffoli, E. Rimondi, B. Fabris, M. Giacca, and G. Zauli
Systemic Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Delivery Shows Antiatherosclerotic Activity in Apolipoprotein E-Null Diabetic Mice
Circulation,
October 3, 2006;
114(14):
1522 - 1530.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Lopez-Garcia, R. M van Dam, L. Qi, and F. B Hu
Coffee consumption and markers of inflammation and endothelial dysfunction in healthy and diabetic women.
Am. J. Clinical Nutrition,
October 1, 2006;
84(4):
888 - 893.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. Westerhout, Y. Fu, M. S. Lauer, S. James, P. W. Armstrong, E. Al-Hattab, R. M. Califf, M. L. Simoons, L. Wallentin, E. Boersma, et al.
Short- and Long-Term Risk Stratification in Acute Coronary Syndromes: The Added Value of Quantitative ST-Segment Depression and Multiple Biomarkers
J. Am. Coll. Cardiol.,
September 5, 2006;
48(5):
939 - 947.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Developed in Collaboration With the European Heart, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al.
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death)
J. Am. Coll. Cardiol.,
September 5, 2006;
48(5):
e247 - e346.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Writing Committee Members, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al.
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Europace,
September 1, 2006;
8(9):
746 - 837.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Juonala, J. S.A. Viikari, T. Ronnemaa, L. Taittonen, J. Marniemi, and O. T. Raitakari
Childhood C-Reactive Protein in Predicting CRP and Carotid Intima-Media Thickness in Adulthood: The Cardiovascular Risk in Young Finns Study
Arterioscler Thromb Vasc Biol,
August 1, 2006;
26(8):
1883 - 1888.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T Kilic, D Ural, E Ural, Z Yumuk, A Agacdiken, T Sahin, G Kahraman, G Kozdag, A Vural, and B Komsuoglu
Relation between proinflammatory to anti-inflammatory cytokine ratios and long-term prognosis in patients with non-ST elevation acute coronary syndrome
Heart,
August 1, 2006;
92(8):
1041 - 1046.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Yilmaz, J. Weber, I. Cicha, C. Stumpf, M. Klein, D. Raithel, W. G. Daniel, and C. D. Garlichs
Decrease in Circulating Myeloid Dendritic Cell Precursors in Coronary Artery Disease
J. Am. Coll. Cardiol.,
July 4, 2006;
48(1):
70 - 80.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Niu, A. Hozawa, S. Kuriyama, K. Ohmori-Matsuda, T. Shimazu, N. Nakaya, K. Fujita, I. Tsuji, and R. Nagatomi
Dietary long-chain n-3 fatty acids of marine origin and serum C-reactive protein concentrations are associated in a population with a diet rich in marine products
Am. J. Clinical Nutrition,
July 1, 2006;
84(1):
223 - 229.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Gori, F. Sofi, A. M. Corsi, A. Gazzini, I. Sestini, F. Lauretani, S. Bandinelli, G. F. Gensini, L. Ferrucci, and R. Abbate
Predictors of Vitamin B6 and Folate Concentrations in Older Persons: The InCHIANTI Study
Clin. Chem.,
July 1, 2006;
52(7):
1318 - 1324.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Tedgui and Z. Mallat
Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways
Physiol Rev,
April 1, 2006;
86(2):
515 - 581.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. J. Boos, R. A. Anderson, and G. Y.H. Lip
Is atrial fibrillation an inflammatory disorder?
Eur. Heart J.,
January 2, 2006;
27(2):
136 - 149.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Rothenbacher, S. Muller-Scholze, C. Herder, W. Koenig, and H. Kolb
Differential Expression of Chemokines, Risk of Stable Coronary Heart Disease, and Correlation with Established Cardiovascular Risk Markers
Arterioscler Thromb Vasc Biol,
January 1, 2006;
26(1):
194 - 199.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. B. Clearfield
C-Reactive Protein: A New Risk Assessment Tool for Cardiovascular Disease
J Am Osteopath Assoc,
September 1, 2005;
105(9):
409 - 416.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. M. Chavan, P. D. Kawle, and N. G. Mehta
Increased sialylation and defucosylation of plasma proteins are early events in the acute phase response
Glycobiology,
September 1, 2005;
15(9):
838 - 848.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Michowitz, E. Goldstein, A. Roth, A. Afek, A. Abashidze, Y. Ben Gal, G. Keren, and J. George
The involvement of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in atherosclerosis
J. Am. Coll. Cardiol.,
April 5, 2005;
45(7):
1018 - 1024.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Panteghini
Role and importance of biochemical markers in clinical cardiology
Eur. Heart J.,
July 2, 2004;
25(14):
1187 - 1196.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. A. Arenas, Y. Xu, P. Lopez-Jaramillo, and S. T. Davidge
Angiotensin II-induced MMP-2 release from endothelial cells is mediated by TNF-{alpha}
Am J Physiol Cell Physiol,
April 1, 2004;
286(4):
C779 - C784.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. B Panagiotakos, C. Pitsavos, C. Chrysohoou, E. Tsetsekou, C. Papageorgiou, G. Christodoulou, and C. Stefanadis
Inflammation, coagulation, and depressive symptomatology in cardiovascular disease-free people; the ATTICA study
Eur. Heart J.,
March 2, 2004;
25(6):
492 - 499.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. A. Hsueh and D. Bruemmer
Peroxisome Proliferator-Activated Receptor {gamma}: Implications for Cardiovascular Disease
Hypertension,
February 1, 2004;
43(2):
297 - 305.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|